NCT03711773 Outcomes of Low-Impact Exercise Program for People With Ankle, Knee, and/or Hip Pain
| NCT ID | NCT03711773 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Missouri-Columbia |
| Condition | Osteoarthritis |
| Study Type | INTERVENTIONAL |
| Enrollment | 10,000 participants |
| Start Date | 2018-11-01 |
| Primary Completion | 2030-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 10,000 participants in total. It began in 2018-11-01 with a primary completion date of 2030-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The primary objective of this study is to study how low-impact group exercise classes affect pain scores in patients with knee, hip, and ankle pain when paired with concurrent standard of care dietitian and behavioral health consults.
Eligibility Criteria
Inclusion Criteria: * 18 and over * Ability to attend classes 3x weekly for 6 months with at least a 66% attendance rate * Ability to concurrently attend standard of care dietitian and behavioral health classes for 6 months * Joint pain (knee, ankle, hip) Exclusion Criteria: * Pregnant * Prisoners
Contact & Investigator
Frequently Asked Questions
Who can join the NCT03711773 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Osteoarthritis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03711773 currently recruiting?
Yes, NCT03711773 is actively recruiting participants. Contact the research team at rucinskik@health.missouri.edu for enrollment information.
Where is the NCT03711773 trial being conducted?
This trial is being conducted at Columbia, United States.
Who is sponsoring the NCT03711773 clinical trial?
NCT03711773 is sponsored by University of Missouri-Columbia. The trial plans to enroll 10,000 participants.